Influenza Clinical Trials

A listing of Influenza medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 493 clinical trials
None
Azole-echinocandin Combination Therapy for Invasive Aspergillosis

The goals of this study are 3-fold: First, the main study and the primary endpoint will evaluate if the overall mortality can be decreased with initial azole-echinocandin combination therapy compared with triazole monotherapy in patients with IA and documented voriconazole susceptibility. Second, the study design described will also allow to …

  • 0 views
  • 16 Oct, 2021
  • 4 locations
None
Scale Up Evaluation of a Physical Activity Program for Adults With Physical Disability

The study uses a theory-driven eHealth platform and innovative physical activity (PA) program referred to as movement-to-music (M2M) to deliver a customized, home-based PA intervention for adults with physical disability (PWD). Participants will be recruited through a large physical medicine and rehabilitation network of clinics specializing in treating patients with …

Accepts healthy volunteers
  • 1 views
  • 04 Oct, 2021
  • 1 location
None
Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years

To evaluate the safety and immunogenicity of quadrivalent influenza virus split vaccine in healthy population aged 3-8 years following different immunization procedures.

vaccination
trivalent influenza vaccine
quadrivalent inactivated influenza vaccine
Accepts healthy volunteers
strain
  • 0 views
  • 15 Jan, 2022
None
The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Live Attenuated freeze-dried Influenza Vaccine has been licensed for use in 2020 (Approval No.S20200002), the sponsor of this research submitted an new application for non freeze-dried Live

  • 0 views
  • 30 Sep, 2021
  • 1 location
None
A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

To assess whether participants treated with ofatumumab 20 mg subcutaneous (s.c.) administered once every 4 weeks (q4) can mount an adequate immune response to inactivated influenza vaccine as

  • 0 views
  • 12 Sep, 2021
  • 4 locations
None
Flu-Bu-Mel Based Conditioning Regimen for Patients With Lymphoid Malignancies Undergoing Allo-HSCT

In this phase II clinical trial, we evaluate the efficacy and feasibility of conditioning regimen of fludarabine 150mg/m2, busulfan 9.6mg/kg, melphalan 100mg/m2 and etoposide 800mg/m2 in patients with lymphoid malignancies.

  • 0 views
  • 04 Jun, 2021
  • 1 location
None
Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine

is designed to assess the safety and immunogenicity of of one and two doses of Sing2016 M2SR H3N2 influenza vaccine (manufactured by FluGen) administered intranasally in seven cohorts of children

Accepts healthy volunteers
  • 0 views
  • 06 Dec, 2021
  • 4 locations
None
Clinical Study of Recombinant Novel Coronavirus COVID-19 Vaccine (CHO Cell) Combined With Influenza Vaccine

Popular topicClinical study of recombinant Novel Coronavirus vaccine (CHO cell) combined with influenza vaccine. Research purpose:Main purpose:To evaluate the immunogenicity of recombinant Novel

Accepts healthy volunteers
  • 0 views
  • 10 Nov, 2021
  • 1 location
None
To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection

To evaluate the antiviral effect of TG-1000 compared with placebo in adult patients with acute uncomplicated influenza virus infection.

  • 0 views
  • 01 Oct, 2021
  • 1 location
None
Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)

Anti-thymocyte globulin (ATG) has been used in severe aplastic anemia as a part of the conditioning regimen. Among the many kinds of ATG preparations, thymoglobulin had been found to be more effective in preventing graft versus host disease (GVHD) and rejection of organ transplants. As the fludarabine based conditioning regimens …

antithymocyte globulin
neutrophil count
aplastic anemia
cell transplantation
severe aplastic anemia
  • 29 views
  • 07 Nov, 2020
  • 1 location